BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21901222)

  • 1. Cytosine-phosphodiester-guanine oligodeoxynucleotide (CpG ODN)-capped hollow mesoporous silica particles for enzyme-triggered drug delivery.
    Zhu Y; Meng W; Hanagata N
    Dalton Trans; 2011 Oct; 40(39):10203-8. PubMed ID: 21901222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo.
    Zheng H; Wen S; Zhang Y; Sun Z
    PLoS One; 2015; 10(10):e0140265. PubMed ID: 26451735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel chitosan-silica/CpG oligodeoxynucleotide nanohybrids with enhanced delivery efficiency.
    Chen S; Zhang H; Chinnathambi S; Hanagata N
    Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3382-8. PubMed ID: 23706224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery.
    Luo Z; Cai K; Hu Y; Zhao L; Liu P; Duan L; Yang W
    Angew Chem Int Ed Engl; 2011 Jan; 50(3):640-3. PubMed ID: 21226142
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
    Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
    ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
    Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
    Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
    Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BN nanospheres functionalized with mesoporous silica for enhancing CpG oligodeoxynucleotide-mediated cancer immunotherapy.
    Zhang H; Cheng T; Lai L; Deng S; Yu R; Qiu L; Zhou J; Lu G; Zhi C; Chen J
    Nanoscale; 2018 Aug; 10(30):14516-14524. PubMed ID: 30024003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
    Yang YJ; Tao X; Hou Q; Chen JF
    Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
    Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
    Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hollow spherical mesoporous phosphosilicate nanoparticles as a delivery vehicle for an antibiotic drug.
    Das SK; Bhunia MK; Chakraborty D; Khuda-Bukhsh AR; Bhaumik A
    Chem Commun (Camb); 2012 Mar; 48(23):2891-3. PubMed ID: 22310528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
    Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
    J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.
    Nadrah P; Porta F; Planinšek O; Kros A; Gaberšček M
    Phys Chem Chem Phys; 2013 Jul; 15(26):10740-8. PubMed ID: 23689395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics.
    Liu Y; Miyoshi H; Nakamura M
    Colloids Surf B Biointerfaces; 2007 Aug; 58(2):180-7. PubMed ID: 17420116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous silica functionalized with an AIE luminogen for drug delivery.
    Li D; Yu J; Xu R
    Chem Commun (Camb); 2011 Oct; 47(39):11077-9. PubMed ID: 21897920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.